Waldenstrom's Macroglobulinemia Clinical Trials
Category:Adult
Status:Active
Displaying 1 Trial
A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia
This research study is studying Daratumumab as a possible treatment for Waldenström Macroglobulinemia.
Diagnosis: Waldenstrom's Macroglobulinemia, Multiple Myeloma
Phase:
Protocol Number: 17-164
